News Release

 

Back
 

Bergen Brunswig Corporation Announces Results For Pharmerica Quarterly Financial Information Available on BBC Web Site

02/08/01
Orange, CA - February 8, 2001 - Bergen Brunswig Corporation announced today that according to the terms of the indenture for the PharMerica 8 3/8 percent senior subordinated notes due 2008, PharMerica, a wholly-owned subsidiary of Bergen Brunswig (NYSE: BBC), has prepared and delivered to the trustee for delivery to note holders an Annual Report of PharMerica, Inc., for the nine months ended September 30, 2000.

This is the transition period following Bergen Brunswig's change of fiscal year-end of PharMerica from December 31 to September 30. You may obtain a copy of this Annual Report by accessing http://www.bergenbrunswig.com/investor/index.cfm.

Corporate Overview

AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel..

Learn More